In the Press

Filters
Type
Sectors
Geography
Companies

Sign up for our free
equity research notes

Register
1601 Results
Embed
Matthew Read comments on FGT conviction in Portfolio Adviser

Matthew Read comments on FGT’s expression of intent in Patrick Sanders’ article: “Rather than changing course at a point when the strategy is deeply out of favour, the board and manager are doubling down to exploit what they see as a valuation opportunity in the aftermath of the ‘SaaSpocalypse’” Read the article here

Matthew Read comments on FGT action following half-year in Investment Week

Matthew Read comments on FGT action following interim results in Patrick Brusnahan’s article: “The board and manager are now taking decisive action. The rebased dividend lifts FGT’s yield to around 4%, bringing the trust into line with its UK equity income peers. One long-running niggle we had was that FGT’s yield was not really high […]

Biotech trusts top performance charts in February
James Carthew comments on FEML as a stand out winner in the emerging markets rally in interactive investor

James Carthew comments on FEML winning in the emerging markets rally in Beth Brearley’s article: “The manager (Nick Price) has the ability to short stocks and has been using that to good effect. The trust also has large positions in some of the winners of the race to develop AI, which has been a big […]

Matthew Read comments on HICL’s results in Trustnet

Matthew Read comments on HICL’s results in Jonathan Jones’ article: “HICL’s results provide a good illustration of why its shareholders were not keen on the now-abandoned merger proposals with TRIG, with HICL benefitting from strong portfolio performance, accretive disposals, disciplined buybacks and improving dividend cover.” Read the article here

Trustnet
Matthew Read comments on CYN appointing Tufton in Trustnet

Matthew Read comments on CYN retaining its team at Tufton in Jonathan Jones’ article: “draws a line under the period of uncertainty” Read the article here

Trustnet
Matthew Read comments on CYN appointing Tufton in Portfolio Adviser

Matthew Read comments on the appointment of Tufton by CYN to retain the team in Lauren Hardy’s article: “We think that shareholders will be reassured that this trust is retaining the team and process behind CYN’s recent strong performance, and that there will be no disruption to the trust’s strategy, risk profile, its enhanced 8% of NAV dividend policy, or […]

Matthew Read comments on CYN appointing Tufton in Investment Week

Matthew Read comments on CYN’s appointment of Tufton as new manager in Jack Roach’s article: “We think that shareholders will be reassured that this trust is retaining the team and process behind CYN’s recent strong performance, and that there will be no disruption to the trust’s strategy, risk profile, its enhanced 8% of NAV dividend […]

Biotech trusts top performance charts in February
Matthew Read comments on the upcoming IEM shareholder vote in Portfolio Adviser

Matthew Read comments on the lack of information for voters in the upcoming IEM shareholder meetings in Patrick Read’s article: “That is not an ideal basis on which retail investors should be expected to make an informed decision, particularly in the case of a specialist trust with a clearly defined environmental mandate,” Read the article […]

Matthew Read comments on new OCI deal in Sharesify

Matthew Read comments on Oakley’s investment in XTEL in James Crux’s article: “The deal also illustrates how private equity investors continue to favour software businesses with large proprietary datasets and clear opportunities to apply AI in practical ways, rather than simply chasing fashionable themes.” Read the article here

James Carthew comments on PCT in ii

James Carthew comments on PCT’s AI thesis in Jennifer Hill’s article: “The game is moving on from a narrow group of US mega-cap stocks to a much broader set of companies that are supplying components and power to support the data-centre capex boom.” Read the article here